Immune cells in the brain called microglia can partially break down large amyloid plaques characteristic of Alzheimer's ...

Piper Sandler downgraded Biogen (NASDAQ:BIIB) to neutral from overweight on Thursday, citing, among other things, the company ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

The Greater Pennsylvania chapter of the Alzheimer’s Association says it’s been a productive and exciting year when it comes ...

The Alzheimer’s Association reports that the disease begins as many as two decades before symptoms develop. Physically, the ...

With two earlier trials meeting their primary endpoints, Axsome claimed it has the data to support a filing for FDA approval ...

A recent study looked at early predictors of Alzheimer’s disease and other dementias. What researchers found could help ...

Nearly 80% of caregiving for people with Alzheimer’s disease or dementia occurs in the home but most caregivers don’t realize ...

Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...

WATERLOO -- Cedar Valley Clinical Research is seeking participants for a clinical study of an investigational medicine for early Alzheimer's disease. The study is for people who range from having no ...

SALT LAKE CITY — After years of stagnation in the search for a cure for Alzheimer's — or at least breakthroughs — 2024 ...